A healthy 12-year-old boy with eczema shows up at the office with an incredibly itchy rash on his legs that has exploded over the last 48 hours. He has a history of dry skin to which his mother regularly applies various moisturizers, including calendula oil.
Itch publishes original scientific papers that contribute to the understanding of the basic mechanisms and clinical aspects of pruritus. Unlike a printed journal, Itch’s online format allows for papers to be published after they’ve been reviewed.
Epidermolysis bullosa (EB) is often described as ‘the worst disease you’ve never heard of,’ and the young sufferer of this condition are referred to as ‘butterfly children’ because their skin is said to be fragile as the wings of butterflies. A potential new topical treatment option, in phase 3 trials, could help to change the EB treatment landscape.
Different agents have become available for scabies treatment, but topical permethrin cream 5 percent is still the go-to therapy, according to an expert. In combination with oral ivermectin, even the most challenging cases of scabies can be addressed effectively.
When presented with a patient suffering from itching, dermatologists should consider treatments other than topical and oral medications, according to an expert who spoke at the 72nd Annual Meeting of the American Academy of Dermatology.
An accurate assessment of the potential cause of chronic pruritus, coupled by a careful selection of current standard treatments as well as new and emerging therapies, can be instrumental in helping to quell the symptoms of this sometimes severely debilitating condition.
The American Academy of Dermatology (AAD) Council on Science and Research’s Research Agenda work group has identified three keys areas — pruritus, cutaneous oncology and performance measurement and outcomes — to target in the future for continuing research in the dermatology specialty.